Symphony Clinical Research Coronavirus (COVID-19) Statement

March 18, 2020

Vernon Hillis, Illinois – As the spread of the Coronavirus pandemic grows, Symphony Clinical Research would like to take the time to reassure our partners and clients that we remain devoted to our mission of providing alternate site solutions to the clinical trial model. While we do not anticipate any disruption in our services or in our ability to begin work on new clinical trials, we’re continually monitoring the spread of the virus and recommendations from the World Health Organization and Centers for Disease Control. It is our intention to continue to provide the highest-quality services at the level our customers and patients have come to expect, following our four key values of accountability, pro-activity, resourcefulness and experience. If you’re interested in contracting Symphony’s services for your clinical trial, please reach out to us at info@symphonyclinicalresearch.com.

Both the Vernon Hills (Illinois, USA) and Gdansk (Poland) Symphony offices remain open, but have taken preventive measures against the spread of Coronavirus by enacting policies on remote work, restricting employee travel, and strict visitor guidelines.

Share